Alerislife Inc (ALR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALR | DGX | DVA | CHE | EHC |
| Company | Alerislife Inc | Quest Diagnostics Inc | Davita Healthcare Partners Inc | Chemed Inc | Encompass Health Corp |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
| Open | 1.3100 | 134.50 | 133.23 | 561.98 | 82.77 |
| High | 1.3200 | 142.46 | 139.24 | 568.91 | 83.92 |
| Low | 1.3034 | 134.50 | 133.23 | 561.98 | 82.67 |
| Last | 1.3200 | 139.50 | 138.14 | 566.51 | 83.64 |
| Change | +0.0100 | +5.24 | +4.63 | +6.09 | +1.17 |
| % Change | +0.76% | +3.90% | +3.47% | +1.09% | +1.42% |
| Volume | 111,900 | 2,790,100 | 990,800 | 92,500 | 537,900 |
| 20-Day Average Volume | 177,105 | 1,106,640 | 528,685 | 76,490 | 747,085 |
| Previous Close | 1.3100 | 134.26 | 133.51 | 560.42 | 82.47 |
| Industry | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3165 | 131.53 | 132.17 | 610.16 | 81.46 |
| 20-Day Raw Stochastic | 37.55% | 82.63% | 91.91% | 10.54% | 69.90% |
| 20-Day Relative Strength | 69.53% | 63.55% | 62.32% | 32.69% | 63.77% |
| Weighted Alpha | -48.10 | +5.62 | +62.88 | +1.70 | +38.73 |
| Today's Opinion | 88% Buy | 56% Buy | 96% Buy | 8% Sell | 100% Buy |
| Previous Opinion | 72% Buy | 40% Buy | 88% Buy | 8% Sell | 100% Buy |
| Last Month's Opinion | 24% Buy | 16% Buy | 100% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.76% since 03/10/23 | +7.23% since 04/22/24 | +4.24% since 04/22/24 | -6.27% since 04/22/24 | +4.12% since 04/22/24 |
| Low | 1.3000 on 03/16/23 | 133.11 on 04/23/24 | 130.96 on 04/26/24 | 557.90 on 04/26/24 | 80.49 on 04/23/24 |
| High | 1.3200 on 03/17/23 | 142.46 on 04/29/24 | 139.24 on 04/29/24 | 622.33 on 04/24/24 | 85.84 on 04/25/24 |
| 1-Month | |||||
| %Chg | -1.49% since 02/17/23 | +4.80% since 03/28/24 | +0.07% since 03/28/24 | -11.75% since 03/28/24 | +1.28% since 03/28/24 |
| Low | 1.3000 on 03/16/23 | 125.42 on 04/18/24 | 125.64 on 04/18/24 | 557.90 on 04/26/24 | 78.53 on 04/18/24 |
| High | 1.3699 on 02/21/23 | 142.46 on 04/29/24 | 139.24 on 04/29/24 | 642.68 on 04/01/24 | 85.84 on 04/25/24 |
| 3-Month | |||||
| %Chg | +80.85% since 12/16/22 | +7.86% since 01/29/24 | +27.54% since 01/29/24 | -5.10% since 01/29/24 | +16.82% since 01/29/24 |
| Low | 0.5487 on 12/30/22 | 123.04 on 02/01/24 | 107.44 on 01/30/24 | 557.90 on 04/26/24 | 70.83 on 02/05/24 |
| High | 1.3699 on 02/21/23 | 142.46 on 04/29/24 | 141.54 on 03/13/24 | 654.62 on 03/15/24 | 85.84 on 04/25/24 |
| 6-Month | |||||
| %Chg | +18.92% since 09/16/22 | +9.26% since 10/27/23 | +79.94% since 10/27/23 | +0.31% since 10/27/23 | +37.45% since 10/27/23 |
| Low | 0.5487 on 12/30/22 | 123.04 on 02/01/24 | 75.47 on 10/30/23 | 555.87 on 10/30/23 | 59.57 on 10/30/23 |
| High | 1.5800 on 09/19/22 | 143.63 on 01/02/24 | 141.54 on 03/13/24 | 654.62 on 03/15/24 | 85.84 on 04/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 43,044 | 15,497,335 | 12,114,876 | 8,563,926 | 8,375,709 |
| Shares Outstanding, K | 32,609 | 111,092 | 87,700 | 15,117 | 100,140 |
| Annual Sales | 942,390,000 | 9,252,000,000 | 12,140,150,000 | 2,264,420,000 | 4,801,200,000 |
| Annual Net Income | -29,930,000 | 854,000,000 | 691,540,000 | 272,510,000 | 352,000,000 |
| Last Quarter Sales | 182,660,000 | 2,366,000,000 | 3,145,750,000 | 589,230,000 | 1,316,000,000 |
| Last Quarter Net Income | -8,510,000 | 194,000,000 | 150,670,000 | 65,020,000 | 112,500,000 |
| 60-Month Beta | 0.96 | 0.91 | 1.04 | 0.42 | 0.94 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.22 on 11/02/22 | 2.04 on 04/23/24 | 1.87 on 02/13/24 | 5.20 on 04/24/24 | 1.12 on 04/24/24 |
| Latest Earnings Date | 03/22/23 | 04/23/24 | 05/02/24 | 04/24/24 | 04/24/24 |
| Most Recent Dividend | N/A | 0.710 on 01/16/24 | N/A | 0.400 on 02/23/24 | 0.150 on 03/28/24 |
| Next Ex-Dividends Date | N/A | 01/16/24 | N/A | 02/23/24 | 03/28/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.41 | 15.93 | 26.30 | 21.26 |